NCT04050436Phase 2Active not recruiting

Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer

Study sponsor: Replimune, Inc.

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2025-09Estimated
Enrollment · participants231Actual
Source updated2025-01-27Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.